Search alternatives:
decrease processes » disease processes (Expand search), decay processes (Expand search), increase process (Expand search)
decrease decrease » decrease release (Expand search), disease decreases (Expand search), decreases disease (Expand search)
clinical safety » clinical severity (Expand search)
safety decrease » safety degree (Expand search), symmetry decrease (Expand search), opacity decrease (Expand search)
decrease asian » decrease in (Expand search)
asian decrease » can decrease (Expand search), via decrease (Expand search), acid decrease (Expand search)
decrease after » increase after (Expand search), disease after (Expand search)
decrease processes » disease processes (Expand search), decay processes (Expand search), increase process (Expand search)
decrease decrease » decrease release (Expand search), disease decreases (Expand search), decreases disease (Expand search)
clinical safety » clinical severity (Expand search)
safety decrease » safety degree (Expand search), symmetry decrease (Expand search), opacity decrease (Expand search)
decrease asian » decrease in (Expand search)
asian decrease » can decrease (Expand search), via decrease (Expand search), acid decrease (Expand search)
decrease after » increase after (Expand search), disease after (Expand search)
1
“... met the defined criteria for this review. After a comprehensive analysis, it can be concluded that...”
Access document
Access document
Article
2
3
“... multicentre, controlled clinical trial compared the efficacy and safety of atorvastatin and bezafibrate...”
Access document
Access document
Article
4
5
6
7
8
“... BS safety. Methods: This was a randomized clinical trial involving 34 patients divided into a control group...”
Access document
Access document
Article
9
“...Trial Design: Open-label, randomised, controlled, pilot proof-of-concept clinical trial. Methods...”
Access document (1)
Access document (2)
Access document (1)
Access document (2)
Article
10
11
12
13
14
“... showed that fibres promote overall improvement of symptoms and bleeding; and decrease recurrence after...”
Access document
Access document
Article
15
16
“..., it can significantly decrease the mortality rate and improve the health of patients; however, as in other...”
Access document
Access document
Article
17
“.... Clinical evaluation at baseline and 6 months after stem cell therapy to assess heart function included...”
Access document
Access document
Article
18
19
“... g/dL) and a lead concentration of 59 μg/dL. This was reported about four months after starting work...”
Access document
Access document
Article
20
“... I / II clinical trial that examines the safety and effectiveness of a new biological therapy for (SR-aGVHD...”
Access document
Access document